aTyr Pharma Finds $76M

San Diego-based biopharmaceuticals developer aTyr Pharma has raised a big, $76M Series E funding round, the company said late Tuesday. According to aTyr, the funding as led by Sofinnova Ventures and an un-named, large institutional investor. The funding also included T. Rowe Price Associates, Federated Investors, Deerfield, Rock Springs Capital Management, EcoR1 Capital, Sphera Global Healthcare and two other un-named institutional investors, in addition to its current venture capital partners. The company said the new funds go towards its clinical development program and pipeline expansion. aTyr's pharmaceuticals are aimed at treating severe rare diseases in the immune system area. More information »